RE: DSE TC Friday Jan 26

Hi All, 


I've added some dummy data to the resources section of DSE.  Adverse
events, vital signs, treatment and demog. 

I think it's internally consistent for the most part, though I'm sure
you could find errors (e.g. males having female AE's, serious adverse
events that are clearly only minor etc). 


I've created a fictional 300 subject 5 arm multi visit trial with 2 of
the arms as dose escalations.  

There are also multiple vital signs taken at each visit.  

It should be obvious what the columns refer to.  

Now I've written the code it should also be easy to mock up labs,
primary diagnosis, some sort of efficacy measure etc for these subjects.


I haven't had time to get into a CDISC format but will attempt to do so
at a later stage. 







[] On Behalf Of Eric Neumann
Sent: Thursday, January 25, 2007 4:23 PM
Subject: DSE TC Friday Jan 26




Friday, 26 January, 8:30am-9:30am/13:30-14:30 UTC <http:// 


  for a duration of 1 hour

Zakim Bridge +1.617.761.6200 <tel:+1.617.761.6200> , conference code  

3731 ("DSE1")

Coordinator: Eric Neumann <
%253E> >




a) Attendance

b) Propose next DSE call Feb 9, 2007

c) Upcoming DIA CDM meeting, March 18, Florida

d) Discuss SDTM RDF example :

e)    Possible Demo plans: Banff WWW2007, May ; DDT Boston (August?)--
what will it require?






Eric Neumann, PhD

co-chair, W3C Healthcare and Life Sciences,

and Senior Director Product Strategy

Teranode Corporation

411 1st Avenue South, Suite 700

Seattle, WA 98104

+1 (781)856-9132 


Unless expressly stated otherwise, this message is confidential and may be privileged.  It is intended for the addressee(s) only.  Access to this E-mail by anyone else is unauthorized.  If you are not an addressee, any disclosure or copying of the contents of this E-mail or any action taken (or not taken) in reliance on it is unauthorized and may be unlawful.  If you are not an addressee, please inform the sender immediately.

Received on Thursday, 8 February 2007 21:44:20 UTC